Search Results 1461-1470 of 14801 for anti-TNF drugs

  1. Neomycin, Polymyxin B, And Hydrocortisone (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Cortisporin. Descriptions. Neomycin, polymyxin B, and ...

  2. Fibrinogen (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. RiaSTAP. Descriptions. Fibrinogen injection is used to ...

  3. Publications - Stacey A. Rizza, M.D. - Mayo Clinic

    Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections Drugs of the Future 2018. 2018; 43( ...

  4. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

    This randomized phase II trial studies how well lenalidomide improves immune response to pneumococcal 13-valent conjugate vaccine in patients with chronic ...

  5. Acetaminophen, Caffeine, And Dihydrocodeine (Oral Route) Description and Brand Names - Mayo Clinic

    It has also been used for migraine headaches. Dihydrocodeine belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the ...

  6. Sodium Nitrite And Sodium Thiosulfate (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Nithiodote. Descriptions. Sodium nitrite and sodium ...

  7. Testosterone (Topical Application Route) Precautions - Mayo Clinic

    The results of some tests may be affected by this medicine. Do not take other medicines unless they have been discussed with your doctor. This includes ...

  8. Abacavir, Dolutegravir, And Lamivudine (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

    Participation eligibility · Any approved anti-cancer therapy within 3 weeks prior to initiation of study treatment · Treatment with any other investigational ...

  10. Trastuzumab (Intravenous Route) Precautions - Mayo Clinic

    Use an effective form of birth control to keep from getting pregnant during therapy and for 7 months after the last dose of this medicine. If you think you have ...